Oxford Professor Lowers Coronavirus Vaccine's Odds of Meeting September Deadline

Clinical trial results from an experimental coronavirus vaccine AstraZeneca (NYSE: AZN) licensed from Oxford University might not be ready this September as hoped. In an interview with The Telegraph, the director of Oxford's Jenner Institute, Professor Adrian Hill, said the chances we'll see meaningful trial results by September are increasingly slim due to successful COVID-19 containment efforts. 

In April, Prof. Hill said a million doses could be ready by September if results from ongoing efficacy tests prove ChAdOx1 nCoV-19 is safe and effective. Thanks to successful containment efforts, Hill thinks the number of new infections in the U.K. will be too few to draw any meaningful conclusions at such an early date. Out of around 10,000 people expected to enroll in the trial, the researcher expects less than 50 will catch the virus.

Image source: Getty Images.

Continue reading

Source Fool.com